NEUROCANNOL Trademark

Trademark Overview


On Thursday, June 10, 2021, a trademark application was filed for NEUROCANNOL with the United States Patent and Trademark Office. The USPTO has given the NEUROCANNOL trademark a serial number of 79318781. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, October 17, 2022. This trademark is owned by CDA Health Pty Ltd. The NEUROCANNOL trademark is filed in the Pharmaceutical Products category with the following description:

Medical marijuana; pharmaceutical preparations; pharmaceutical preparations and substances for medical purposes; medicine; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and conditions; herbal extracts for medicinal purposes; herbal preparations for medical purposes; medicinal oils; transdermal patches for administering pharmaceuticals; smoking herbs for medical purposes; preparations for the relief of pain; pharmaceutical preparations for the treatment of eye diseases and conditions; analgesics; topical dermatological products for medical purposes; topical pharmaceutical preparations; compounds for treating cancer; pharmaceutical preparations and substances for the treatment of depression, anxiety and related mood disorders; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes; anti-inflammatory preparations; herbal preparations for use in medicine
neurocannol

General Information


Serial Number79318781
Word MarkNEUROCANNOL
Filing DateThursday, June 10, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, October 17, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical marijuana; pharmaceutical preparations; pharmaceutical preparations and substances for medical purposes; medicine; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and conditions; herbal extracts for medicinal purposes; herbal preparations for medical purposes; medicinal oils; transdermal patches for administering pharmaceuticals; smoking herbs for medical purposes; preparations for the relief of pain; pharmaceutical preparations for the treatment of eye diseases and conditions; analgesics; topical dermatological products for medical purposes; topical pharmaceutical preparations; compounds for treating cancer; pharmaceutical preparations and substances for the treatment of depression, anxiety and related mood disorders; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes; anti-inflammatory preparations; herbal preparations for use in medicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCDA Health Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Monday, November 6, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 17, 2023FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 17, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, February 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, October 17, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, October 17, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, October 17, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, April 24, 2022REFUSAL PROCESSED BY IB
Friday, April 1, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 1, 2022REFUSAL PROCESSED BY MPU
Sunday, March 6, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, March 5, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 2, 2022ASSIGNED TO EXAMINER
Saturday, September 4, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 26, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB